Literature DB >> 1672889

Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method.

J Delforge1, A Syrota, J P Lançon, K Nakajima, C Loc'h, M Janier, J M Vallois, J Cayla, C Crouzel.   

Abstract

The in vivo quantification of myocardial beta-adrenergic receptor has been obtained in five closed-chest dogs using positron emission tomography (PET). The ligand was racemic (+/-)[11C] CGP 12177, a very potent hydrophilic antagonist of the beta-adrenergic receptor. A kinetic method appeared unsuitable because of the presence of metabolites which made the input function difficult to measure and also inaccurate. Therefore, a graphical method, based on a particular protocol, was proposed. The animals were injected with a trace amount of (+/-)[11C]CGP 12177, which was followed 40 min later by a second injection of radioligand with a low-specific activity. An additional injection of an excess of unlabeled CGP 12177 was administered after 90 min and allowed for the estimation of the dissociation rate constant. The main advantage of this graphical approach is that the results are obtained without having to measure the input function and therefore without estimating the metabolites. The average value of Bmax was 31 +/- 4 pmole/ml of tissue and the dissociation constant was 0.014 +/- 0.002 min-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672889

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  31 in total

1.  Iterative optimal design of PET experiments for estimating beta-adrenergic receptor concentration.

Authors:  R F Muzic; G M Saidel; N Zhu; A D Nelson; L Zheng; M S Berridge
Journal:  Med Biol Eng Comput       Date:  2000-11       Impact factor: 2.602

Review 2.  Positron emission tomography in paediatric cardiology.

Authors:  R M Quinlivan; R O Robinson; M N Maisey
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 3.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

4.  Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.

Authors:  Richard M de Jong; Antoon T M Willemsen; Riemer H J A Slart; Paul K Blanksma; Aren van Waarde; Jan Hein Cornel; Willem Vaalburg; Dirk J van Veldhuisen; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-11       Impact factor: 9.236

Review 5.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

6.  Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors.

Authors:  F Qing; S U Rahman; M J Hayes; C G Rhodes; P W Ind; T Jones; J M Hughes
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

7.  Imaging of cardiac neuronal and receptor function.

Authors:  N Tamaki
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

Review 8.  Rationale for the rational development of new cardiac imaging agents.

Authors:  D D Miller
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

9.  Assessment of the Effects of Age, Gender, and Exercise Training on the Cardiac Sympathetic Nervous System Using Positron Emission Tomography Imaging.

Authors:  Gwen M Bernacki; Samira Bahrainy; James H Caldwell; Wayne C Levy; Jeanne M Link; John R Stratton
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03-08       Impact factor: 6.053

10.  Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.

Authors:  M P Law
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.